Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects

NYU Langone Medical Center, New York

Weill Cornell Medicine, Hepatology, New York

Columbia University Medical Center, New York

Northwell Health - Sandra Atlaas Bass Center for Liver Diseases, Manhasset

University of Pennsylvania-Perelman Center for Advanced Medicine, Philadelphia

Georgetown University Hospital, Washington D.C.

MedStar Health Research Institute, Washington D.C.

Digestive Disease Associates, PA, Catonsville

The Johns Hopkins Hospital/John G. Bartlett Specialty Practice, Baltimore

Bon Secours Liver Institute of Virginia, Richmond

University of North Carolina at Chapel Hill, Chapel Hill

Duke University Medical Center, Durham

Medical University of South Carolina, Charleston

Atlanta Gastro Associates, Atlanta

UF Health Jacksonville-Gastroenterology Emerson, Jacksonville

UF Hepatology Research at CTRB, Gainesville

Orlando Immunology Center, Orlando

Schiff Center for Liver Diseases/University of Miami, Miami

Southern Therapy and Advanced Research, Jackson

The Ohio State University, Columbus

Univ. of Minnesota Health Clinics and Surgery Center, Inc., Minneapolis

Rush University Medical Center, Chicago

Integris Baptist Medical Center, Oklahoma City

University of California, San Francisco, San Francisco

Stanford University, Palo Alto

Virginia Mason Medical Center, Seattle

University of Washington, Seattle

Atlanta Medical Center, Atlanta

Massachusetts General Hospital, Boston

University of Michigan, Ann Arbor

Virginia Commonwealth University, Richmond